The conventional concepts of the pathogenesis of acute coronary syndromes a
re changing. High-risk lesions are not necessarily the angiographicaly 'tig
ht' stenoses. Rather, vulnerable lesions are those that are unstable, with
a large lipid core and a thin fibrous cap. Plaque instability is closely re
lated to the development of inflammation within the intima and acute corona
ry syndromes result from rupture of a vulnerable atherosclerotic plaque. St
abilization of lesions by modification of structure and content, rather tha
n simple improvement in the luminal diameter, provides a new therapeutic ta
rget. Stabilization may be accomplished through lifestyle changes and appro
priate pharmacologic therapy. In the past few years, it has become evident
that a major beneficial effect of statins is to induce plaque stability and
regression. In fact, statins, in addition to lowering low-density lipoprot
ein cholesterol, have a variety of pleiotropic, or cholesterol-independent,
effects that make them a particularly suitable choice in patients with acu
te coronary syndromes. Among these are improvements in endothelial function
, smooth muscle cells, thrombus formation/platelet function, and inflammati
on. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.